Year archive

Brii Biosciences Limited — 2021 filings

All 40 regulatory filings released by Brii Biosciences Limited (2137) in 2021, sourced directly from the official regulator.

40 Filings

2021 Period

2021 filings (40)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-12-27	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-12-12	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-12-12	English
INSIDE INFORMATION THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES NOVEL NEUTRALIZING ANTIBODY COMBINATION THERAPY FOR THE TREATMENT OF COVID-19 IN CHINA Regulatory Filings	2021-12-08	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-12-05	English
GRANT OF SHARE OPTIONS Regulatory Filings	2021-12-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 Regulatory Filings	2021-12-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 Regulatory Filings	2021-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021 (Revised) Regulatory Filings	2021-10-12	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-10-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021 Regulatory Filings	2021-10-07	English
Next Day Disclosure Return Regulatory Filings	2021-09-29	English
2021 Interim Report Regulatory Filings	2021-09-27	English
Next Day Disclosure Return Regulatory Filings	2021-09-27	English
GRANT OF SHARE OPTIONS Regulatory Filings	2021-09-19	English
Next Day Disclosure Return Regulatory Filings	2021-09-15	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-09-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 Regulatory Filings	2021-09-06	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021 Regulatory Filings	2021-08-26	English
INSIDE INFORMATION ANNOUNCEMENT POSITIVE DATA FROM THE PHASE 3 ACTIV-2 TRIAL EVALUATING COMBINATION BRII-196 AND BRII-198 IN NON-HOSPITALIZED COVID-19 PATIENTS Regulatory Filings	2021-08-25	English
Next Day Disclosure Return Regulatory Filings	2021-08-10	English
DATE OF BOARD MEETING Regulatory Filings	2021-08-09	English
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD Regulatory Filings	2021-08-05	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-08-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 Regulatory Filings	2021-08-05	English
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE Regulatory Filings	2021-07-20	English
List of Directors and their Roles and Functions Regulatory Filings	2021-07-12	English
Terms of Reference of The Strategy Committee Regulatory Filings	2021-07-12	English
Terms of Reference of The Nomination Committee Regulatory Filings	2021-07-12	English
Terms of Reference of The Remuneration Committee Regulatory Filings	2021-07-12	English
Terms of Reference of The Audit Committee Regulatory Filings	2021-07-12	English
Amended and Restated Memorandum and Articles of Association Regulatory Filings	2021-07-12	English
Announcement of Offer Price and Allotment Results Share Issue/Capital Change	2021-07-12	English
GREEN APPLICATION FORM Regulatory Filings	2021-06-30	English
GLOBAL OFFERING Regulatory Filings	2021-06-30	English
GLOBAL OFFERING Regulatory Filings	2021-06-30	English
PHIP (1st submission) Audit Report / Information FY 2020	2021-06-21	English
PHIP (1st submission) Regulatory Filings	2021-06-21	English
Application Proof (1st submission) Audit Report / Information FY 2020	2021-04-08	English
Application Proof (1st submission) Regulatory Filings	2021-04-08	English